Cholangiocarcinoma Foundation 7th Annual Conference

项目摘要 胆管细胞癌(CCA)作为一种罕见的致命性疾病，缺乏足够的关注和资源。的确有 从板凳到床边的整个疾病谱对教育的巨大需求尚未得到满足。AS 因此，胆管癌基金会继续致力于教育所有人 胆管癌界的利益相关者。 作为这一努力的重要组成部分，2020年年会的发展具有以下几个方面 目标：1)增加与会者对关键问题的认识和理解 对胆管细胞癌的预防、诊断、治疗和治愈至关重要；2)确定 在基础、翻译和临床领域迅速变化的进展方面存在差距并凝聚共识 研究；3)促进国际、多学科、交叉合作和分享最佳 通过发展、加强和支持合作实践；4)促进对话 和激励创新。 多学科的听众，包括科学、医学和学术界的代表 社区；政策制定者和监管机构、行业、倡导者、患者和照顾者将 召开会议，提出侧重于循证观点的多样化观点，比较 当前的发展，并总结了在基础、翻译和 界定CCA领域的临床研究。 全球专家社区将审查高危人群的症状、发病率和流行率 人口(预防)；检查流行性感冒的流行病学和病理学特征 由3种不同解剖结构的癌症组成的异质性组(诊断)；并回顾了 可能与临床相关的肿瘤学研究(治疗和治愈)。 这一设置还将提供一个论坛，以吸引和培养早期职业研究人员 在来自全球社区的指导下，有机会发展和扩大他们的教育 知名专家。通过口头摘要、海报会议、演讲者演示、患者 参与和更多，青年调查人员将建立新的联盟，促进对话和 加速全球CCA研究，共同目标是支持基金会的使命 为那些受CCA影响的人找到治疗方法并提高生活质量。

Project Summary As a rare and lethal disease, cholangiocarcinoma (CCA) lacks attention and resources. There is a vast unmet need for education across the entire disease spectrum from bench-to-bedside. As such, the Cholangiocarcinoma Foundation continues to focus its efforts to educate all stakeholders in the cholangiocarcinoma community-at-large. Paramount to that effort, the 2020 Annual Conference has been developed with the following objectives: 1) Increasing the knowledge and understanding of attendees about key issues central to the prevention, diagnosis, treatment, and cure for cholangiocarcinoma; 2) Identifying gaps and gathering consensus on rapidly changing advances in basic, translational, and clinical research; 3) Stimulating international, multi-disciplinary, cross-cooperation and sharing of best practices by developing, strengthening, and supporting collaborations; 4) Fostering dialogue and inspiring innovation. A multidisciplinary audience, including representatives of the scientific, medical and academic communities; policymakers and regulators, industry, advocates, patients and caregivers will convene to present a diversity of perspectives focused on evidence-based opinion, compare current developments, and summarize emerging developments in basic, translational and clinical research defining the field of CCA. A global community of experts will review symptoms, incidence, and prevalence in high risk populations (prevention); examine epidemiological and pathological features of the heterogeneous group of 3 anatomically distinct cancers (diagnosis); and review advances in oncology research that are likely to be clinically relevant (treatment and cure). This setting will also provide a forum to attract and nurture early career researchers with opportunities to develop and expand their education with mentorship from a global community of renowned experts. Through oral abstracts, poster sessions, speaker presentations, patient engagement and more, Young Investigators will forge new alliances, stimulate dialogue and accelerate global CCA research with the common goal of supporting the Foundation's mission to find a cure and improve the quality of life for those affected by CCA.